Pat Garcia-Gonzalez: A Bold Plan to Double Impact and Reach 100,000 Patients by 2031
Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, shared a post on LinkedIn:
”I am excited to invite you to our 2026 State of the Organization, a virtual presentation where I’ll share our vision and priorities at The Max Foundation.
In the year ahead, we are deepening our commitment to what matters most: developing a strategy to more than double our impact by reaching 100,000 patients annually by 2031. This is the driving force behind every partnership we build and every innovation we pursue.
During the presentation, I’ll discuss four organizational priorities for the year and what they mean in real world practice. In 2026, we’re building on that foundation and reaching farther than ever before.
I hope you’ll join me to hear more about how, together, we can continue advancing health equity around the world.
Date: February 19, 2026, 8:00 AM PT
Let’s make this a year of bold impact—one patient, one partnership, one breakthrough at a time.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis